Survodutide Research# Key trials include the obesity Phase 2 (Lancet Diabetes & Endocrinology, 2024, 18.7% weight loss), MASH Phase 2 (NEJM, 2024, 62% MASH resolution), SYNCHRONIZE-1/2 (Phase 3, obesity, fully enrolled), and LIVERAGE (Phase 3, MASH, ongoing)
Beginning GLP-1s Set up nutrition and training that work with the medication from day one, so the weight you lose is fat, not muscle
These advanced systems utilize active water separation technology along with a series of gravity settling tanks and weirs to efficiently remove stone particles from the water
More affordable alternatives may be available and worth discussing with a healthcare provider
Common side effects include injection site reactions (burning, pain, swelling, redness), headache, mild diarrhea, and upset stomach
These therapies extend skin-tightening treatments and can enhance contour where volume loss and laxity overlap